Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation.
D000328:Adult; D000613:Aminobutyrates / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications; D013035:Spasm / Q000188:drug therapy*; D013119:Spinal Cord Injuries / Q000150:complications; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000613:Aminobutyrates; D005680:gamma-Aminobutyric Acid